Related Experiment Video
Updated: Jan 1, 2026

Author Spotlight: Double Posteromedial Approach for Treating Posterior Cruciate Ligament Cysts
Published on: October 20, 2023
Editorial Commentary: Defining Improvement After Arthroscopic Meniscal Surgery-How Much of a Difference Does a
Patient-centered metrics like minimal clinically important difference and patient acceptable symptom state help interpret patient-reported outcomes. These scores provide a patient-centered view of treatment effectiveness and satisfaction.
Area of Science:
- Health Outcomes Research
- Clinical Significance
- Patient-Reported Outcomes
Background:
- Patient-centered metrics, including minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS), are crucial for interpreting patient-reported outcome (PRO) scores.
- These metrics enable a more meaningful clinical interpretation of score changes, quantifying the degree of improvement and patient satisfaction.
Discussion:
- When MCID, SCB, and PASS are derived concurrently, they facilitate patient-centered analyses.
- This approach identifies patient populations likely to respond to treatment and predicts their potential level of improvement and satisfaction.
Key Insights:
- These metrics offer a patient-centered perspective beyond simple mean score changes.
- They are essential for understanding the clinical significance of PROs in research and practice.
Outlook:
- Further research is needed to validate these metrics across diverse patient populations and conditions.
- Integrating these patient-centered metrics into clinical trials and practice can enhance the evaluation of treatment efficacy.
More Related Videos
07:24Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
Published on: January 23, 2018
05:07Author Spotlight: Implementing the Enhanced Recovery After Surgery Concept in Rehabilitation Following Anterior Cruciate Ligament Reconstruction
Published on: March 1, 2024